Two studies suggest DSM265 is a medium-potency, slowly eliminated, well-tolerated antimalarial.
Neuraminidase inhibitors, the antiviral drugs given to fight and prevent influenza, pose no safety risks to fetuses or newborns, according to a new study published today in BMJ. This is the largest study on antiviral use and safety in pregnancy conducted to date.
The first known case of malaria resistant to the essential drug artemisinin was reported yesterday in the New England Journal of Medicine.
Five more babies have been born in the United States with Zika-related birth defects, according to updated data from the Centers for Disease Control and Prevention (CDC). There are now 43 babies in the country with documented defects from the mosquito-borne illness.
China reported two more H7N9 avian influenza cases, including the season's second case detected in Beijing, according to official sources and state media.
UK researchers report that a frontline drug combo failed in 4 patients.
The Los Angeles County Department of Public Health (LAC DPH) reported yesterday that a bacterial isolate harboring the MCR-1 gene, which confers resistance to the last-resort antibiotic colistin, has been identified in a patient with an Escherichia coli infection.
In updates yesterday and today, Saudi Arabia's Ministry of Health (MOH) announced five new MERS-CoV cases, one of them fatal.
Yesterday the MOH reported four new MERS-CoV (Middle East respiratory syndrome coronavirus) cases, two in Riyadh and a pair from Buraydah, located about 200 miles northwest of Riyadh in the north central part of the country.
In other developments, research teams describe viral levels in semen and thrombocytopenia as a complication.
Achievements include more diagnostic testing in kids and prevention during pregnancy.